NCT00061581View on ClinicalTrials.gov

Experimental Bone Marrow Transplant Protocol

PHASE2CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

May 19, 2003

Primary Completion Date

December 28, 2007

Study Completion Date

June 14, 2017

Conditions
Acute Lymphocytic LeukemiaChronic Myeloid LeukemiaAcute Myelocytic LeukemiaMyelodysplastic SyndromesMyeloproliferative Disorders
Interventions
DEVICE

Isolex 300i Stem Cell Selection

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Heart, Lung, and Blood Institute (NHLBI)

NIH

NCT00061581 - Experimental Bone Marrow Transplant Protocol | Biotech Hunter | Biotech Hunter